# String Bio Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/string-bio-private

- Industry: Biotechnology
- Headquarters: Bangalore, India
- Website: www.stringbio.com
- Total disclosed funding: $20M
- Latest round: Series B (Jul 11, 2022)
- Investors on record: 5

## About

String Bio Private Limited is an innovative company focused on developing sustainable protein solutions through advanced fermentation technology, catering to diverse sectors including nutrition and agriculture.Founded in 2013 in Bangalore, India, String Bio Private Limited specializes in creating transformative products using a unique gas fermentation platform. The company raised USD 20.00 mn in SERIES B funding in July 2022, led by Woodside Energy (USA) Inc., with participation from Ankur Capital, Dare Ventures, Redstart Labs, and Zenfold Ventures. Under the leadership of CEO Ezhil Subbian, String Bio has successfully completed a total of 3 funding deals to date, highlighting its commitment to growth and innovation in the biotechnology sector.String Bio specializes in transformative products derived from a unique gas fermentation platform that utilizes synthetic biology and fermentation processes to create high-quality protein and nutritional solutions. The company’s core offerings cater to sectors including animal nutrition, human nutrition, and agriculture, addressing market demands for sustainable and efficient food production. Their flagship products focus on providing protein alternatives, leveraging innovative processes to convert methane gas into protein-rich ingredients for both animal feed and human food applications. String Bio’s solutions are designed for scalability and adaptability, serving clients across various geographical markets including North America, Europe, and Asia, where they work with manufacturers, distributors, and end users in the nutrition and agriculture industries.In the most recent fiscal year of 2023, String Bio reported revenue of USD 1,184,648.20 and an EBITDA of USD 42,089.50. The company generates revenue through B2B transactions, partnering with manufacturers and distributors to supply its innovative protein solutions. The company operates on a structured transaction model that includes direct supply agreements and long-term partnerships with clients in diverse markets, enabling clients to access high-quality, sustainable ingredients tailored to their production needs. Pricing plans are based on contractual agreements which reflect the value of String Bio's proprietary technology and the competitive advantages it offers.Following its latest funding round in July 2022, String Bio plans to leverage the USD 20.00 mn raised to support product development aimed at decarbonization and enhancing manufacturing capabilities. The company is also focusing on expanding its reach into new markets and geographic regions, specifically targeting growth opportunities in North America and Europe by 2025. String Bio is poised to launch new products designed to meet the evolving demands of sustainable food production, with release dates yet to be announced.

## Funding rounds

- Series B, Jul 11, 2022, $20M — Woodside Energy (USA) Inc., Ankur Capital, Redstart Labs, Dare Ventures, Zenfold Ventures

## Investors

- Woodside Energy (USA) Inc. — Series B
- Ankur Capital (https://capitalatlas.ai/funds/ankur-capital) — Series B
- Redstart Labs — Series B
- Dare Ventures (https://capitalatlas.ai/funds/dare-ventures) — Series B
- Zenfold Ventures (https://capitalatlas.ai/funds/zenfold-ventures) — Series B